Our in vitro study revealed that melatonin or an LSD1 inhibitor, pargyline, strongly inhibit the proliferation of tongue (SAS, SCC25, and SCC4) and gingival (OEC-M1) cancer cells. This evidence concerns the gene KDM1A and cancer.